← Verisk Analytics overview

Verisk Analytics vs Equifax: why the prices moved differently

Weekly · monthly · quarterly news summaries, side by side in time

Verisk Analytics Inc (VRSK)

Q3 2026
▲2▼2

Verisk's steady growth and buyback offset by revived acquisition and valuation worries

  • Steady Q2 growth and $200M buyback Verisk reported Q2 revenue up 4.3% to $806 million and earnings per share up 5.3% to $1.98. The company also announced a $200 million accelerated share buyback, returning cash to shareholders.

    This shows the company's core financial performance and capital return, which supported the stock.

  • Catastrophe-modeling demand and new products Earthquakes in Venezuela and Japan boosted demand for Verisk's catastrophe-modeling services. New offerings like McKenzie Intelligence, a data center exposure database, a fraud platform, and Truepic tools expand its subscription products.

    These factors drove demand for Verisk's services and expanded its product lineup.

  • Revived AccuLynx acquisition adds uncertainty A Delaware court revived the terminated $2.35 billion AccuLynx acquisition, pending FTC approval. This introduces cost and regulatory risk, and the stock fell 6.5% and later 4.71% on the news.

    This event created uncertainty and negatively impacted the stock price.

  • Slow long-term growth and rich valuation Analysts flagged slow long-term growth (about 1.9% revenue and 9.3% EPS) against a rich ~24x forward P/E. Verisk merely reaffirmed guidance while net income slipped to $228.6 million, missing EPS expectations.

    This highlights concerns about growth and valuation that weighed on the stock.

August 2026
▼3▲1

Verisk's growth stays slow as legal setback and product launches shape the story

  • Slow growth and rich valuation draw caution Analysts flagged Verisk's weak long-term growth — about 1.9% yearly revenue and 9.3% EPS — against a high forward P/E near 24x, and recommended avoiding the stock. When a company grows slowly but trades expensively, investors worry the price is ahead of the business, which pressures the shares.

    Explains the core valuation and growth concern weighing on VRSK.

  • Guidance reaffirmed, not raised, and profit slips Verisk repeated its 2026 outlook instead of raising it, disappointing investors who wanted an upgrade, and quarterly net income fell to $228.6 million with adjusted EPS of $1.98 missing expectations. Flat guidance plus weaker profit signals slower momentum, which pushed the stock down.

    The reaffirmed guidance and profit miss are the main negative earnings driver this period.

  • Delaware court ruling on AccuLynx A Delaware Chancery Court ruled against Verisk over AccuLynx; the company says it strongly disagrees and may appeal. Legal uncertainty can mean costs or damages, and the stock fell 4.71% on the news, showing investors see real risk in the outcome.

    A new legal setback that directly moved the shares and adds uncertainty.

  • New products expand Verisk's data and fraud offerings Verisk bought McKenzie Intelligence for catastrophe analytics, launched a U.S. Data Center Exposure Database and a Fraud Discovery platform, and added Truepic's verified photo and video tools to ClaimSearch. These deepen its subscription products and open new markets like data center risk, supporting future revenue.

    Shows the growth pipeline that offsets the slow headline numbers.

Latest
▼3▲1

Verisk's growth stays slow as legal setback and product launches shape the story

  • Slow growth and rich valuation draw caution Analysts flagged Verisk's weak long-term growth — about 1.9% yearly revenue and 9.3% EPS — against a high forward P/E near 24x, and recommended avoiding the stock. When a company grows slowly but trades expensively, investors worry the price is ahead of the business, which pressures the shares.

    Explains the core valuation and growth concern weighing on VRSK.

  • Guidance reaffirmed, not raised, and profit slips Verisk repeated its 2026 outlook instead of raising it, disappointing investors who wanted an upgrade, and quarterly net income fell to $228.6 million with adjusted EPS of $1.98 missing expectations. Flat guidance plus weaker profit signals slower momentum, which pushed the stock down.

    The reaffirmed guidance and profit miss are the main negative earnings driver this period.

  • Delaware court ruling on AccuLynx A Delaware Chancery Court ruled against Verisk over AccuLynx; the company says it strongly disagrees and may appeal. Legal uncertainty can mean costs or damages, and the stock fell 4.71% on the news, showing investors see real risk in the outcome.

    A new legal setback that directly moved the shares and adds uncertainty.

  • New products expand Verisk's data and fraud offerings Verisk bought McKenzie Intelligence for catastrophe analytics, launched a U.S. Data Center Exposure Database and a Fraud Discovery platform, and added Truepic's verified photo and video tools to ClaimSearch. These deepen its subscription products and open new markets like data center risk, supporting future revenue.

    Shows the growth pipeline that offsets the slow headline numbers.

July 2026
▲2▼2

Verisk's growth steady, but court revives $2.35B AccuLynx deal

  • Q2 revenue up 4.3%, buyback announced Verisk reported second-quarter revenue of $806 million, up 4.3% from a year ago, with adjusted profit rising and adjusted earnings per share up 5.3% to $1.98. The company also announced a $200 million accelerated share buyback and reaffirmed its full-year outlook. Steady growth and cash returned to shareholders support the stock.

    This is the core earnings update that shows the business is growing and returning cash, a fundamental positive for the stock.

  • Catastrophe loss estimates keep Verisk in demand Verisk issued loss estimates for the Venezuela earthquakes (over $10 billion economic) and the Kumamoto, Japan earthquake (insured losses $1.4–2.1 billion). These events highlight demand for Verisk's risk modeling services, as insurers and others rely on its estimates after disasters. More frequent catastrophes can drive long-term demand for its products.

    Shows a recurring demand driver for Verisk's core catastrophe modeling business, which can support future revenue.

  • Court forces Verisk to pursue AccuLynx deal A Delaware judge ruled that Verisk must try to complete its $2.35 billion acquisition of AccuLynx, which Verisk had terminated in December. The judge found Verisk's withdrawal invalid and said AccuLynx can recover costs. The deal still needs FTC approval, so uncertainty and potential financial burden weigh on the stock.

    This legal setback creates uncertainty and potential costs, directly pressuring the stock price.

  • Market reacts sharply to court ruling Verisk shares fell more than 6.5% after the Delaware court decision, reflecting investor concern about the forced acquisition and its unresolved regulatory review. The drop shows the market sees the ruling as a negative, at least in the short term, due to added uncertainty and potential integration costs.

    Captures the immediate market impact of the court ruling, confirming it as a negative driver.

▲2▼2

Verisk's growth steady, but court revives $2.35B AccuLynx deal

  • Q2 revenue up 4.3%, buyback announced Verisk reported second-quarter revenue of $806 million, up 4.3% from a year ago, with adjusted profit rising and adjusted earnings per share up 5.3% to $1.98. The company also announced a $200 million accelerated share buyback and reaffirmed its full-year outlook. Steady growth and cash returned to shareholders support the stock.

    This is the core earnings update that shows the business is growing and returning cash, a fundamental positive for the stock.

  • Catastrophe loss estimates keep Verisk in demand Verisk issued loss estimates for the Venezuela earthquakes (over $10 billion economic) and the Kumamoto, Japan earthquake (insured losses $1.4–2.1 billion). These events highlight demand for Verisk's risk modeling services, as insurers and others rely on its estimates after disasters. More frequent catastrophes can drive long-term demand for its products.

    Shows a recurring demand driver for Verisk's core catastrophe modeling business, which can support future revenue.

  • Court forces Verisk to pursue AccuLynx deal A Delaware judge ruled that Verisk must try to complete its $2.35 billion acquisition of AccuLynx, which Verisk had terminated in December. The judge found Verisk's withdrawal invalid and said AccuLynx can recover costs. The deal still needs FTC approval, so uncertainty and potential financial burden weigh on the stock.

    This legal setback creates uncertainty and potential costs, directly pressuring the stock price.

  • Market reacts sharply to court ruling Verisk shares fell more than 6.5% after the Delaware court decision, reflecting investor concern about the forced acquisition and its unresolved regulatory review. The drop shows the market sees the ruling as a negative, at least in the short term, due to added uncertainty and potential integration costs.

    Captures the immediate market impact of the court ruling, confirming it as a negative driver.

Equifax Inc (EFX)

Q3 2026
▲2▼2

Equifax grew but faced pricing and margin pressures

  • Strong revenue and earnings beat Equifax beat Q2 earnings with revenue up 10.6%, mortgage revenues up 40%, and USIS up 17%, showing robust demand across key segments.

    This point highlights the positive financial performance that likely supported the stock price.

  • AI cost savings and acquisitions Equifax doubled AI cost savings targets to $150 million, agreed to acquire Mexico's Círculo de Crédito for $750 million, and launched a healthcare credentialing product, signaling growth initiatives.

    These strategic moves demonstrate efforts to boost efficiency and expand into new markets.

  • Regulatory changes pressure pricing FHFA reforms ended FICO's monopoly, allowing VantageScore, and Equifax locked mortgage scores at $1 through 2028, pressuring pricing. A possible bi-merge requirement could cut demand for three-bureau reports.

    These regulatory shifts directly threaten Equifax's pricing power and demand for its core products.

  • Margin declines and rising leverage Margins fell across all segments amid weak mortgage markets and rising costs. Equifax also added $1 billion in debt after heavy buybacks, raising leverage concerns.

    Deteriorating margins and increased debt could weigh on investor sentiment and financial flexibility.

August 2026
▲2▼2

Equifax's mortgage pricing power shrinks as VantageScore push and debt load weigh

  • Mortgage pricing pressure from VantageScore adoption Equifax is holding VantageScore 4.0 mortgage scores at just $1 through 2028, and nearly 2,000 lenders have adopted it. This locks in very low pricing for a key product, which can shrink revenue per mortgage even as volumes grow. The earlier FHFA reforms that ended FICO's monopoly are the root cause, and this pricing move confirms the pressure is real and lasting.

    This is the biggest new development directly affecting Equifax's mortgage revenue and pricing power.

  • Rising debt load from $1 billion bond sale Equifax raised $1 billion in new debt in August, adding to leverage after buying back $1.49 billion of stock since April 2025. Higher interest costs can eat into profits if earnings don't grow fast enough. Analysts already flag the company's high debt level, so this makes the balance sheet a bigger risk.

    New debt issuance increases financial risk and interest costs, a key factor for investors.

  • Strong Q2 earnings and raised AI savings target Equifax beat second-quarter earnings and revenue estimates, with mortgage revenues up 40% and USIS revenues up 17%. Management doubled its AI-driven cost savings target to $150 million and agreed to buy Mexico's Circulo de Credito for $750 million. This shows the core business is growing and cost cuts are helping profits.

    This is the most important positive fundamental news for Equifax this period.

  • New healthcare screening product expands verification business Equifax launched Healthcare Report Credential ID, an automated tool to verify healthcare licenses and certifications. With projected shortages of over 106,000 doctors and 267,000 nurses by 2027, hospitals need faster onboarding. This adds a new product to Equifax's fast-growing verification services, which already drive much of its profit growth.

    New product launch shows Equifax expanding its higher-margin verification business beyond traditional credit reports.

Latest
▲2▼2

Equifax's mortgage pricing power shrinks as VantageScore push and debt load weigh

  • Mortgage pricing pressure from VantageScore adoption Equifax is holding VantageScore 4.0 mortgage scores at just $1 through 2028, and nearly 2,000 lenders have adopted it. This locks in very low pricing for a key product, which can shrink revenue per mortgage even as volumes grow. The earlier FHFA reforms that ended FICO's monopoly are the root cause, and this pricing move confirms the pressure is real and lasting.

    This is the biggest new development directly affecting Equifax's mortgage revenue and pricing power.

  • Rising debt load from $1 billion bond sale Equifax raised $1 billion in new debt in August, adding to leverage after buying back $1.49 billion of stock since April 2025. Higher interest costs can eat into profits if earnings don't grow fast enough. Analysts already flag the company's high debt level, so this makes the balance sheet a bigger risk.

    New debt issuance increases financial risk and interest costs, a key factor for investors.

  • Strong Q2 earnings and raised AI savings target Equifax beat second-quarter earnings and revenue estimates, with mortgage revenues up 40% and USIS revenues up 17%. Management doubled its AI-driven cost savings target to $150 million and agreed to buy Mexico's Circulo de Credito for $750 million. This shows the core business is growing and cost cuts are helping profits.

    This is the most important positive fundamental news for Equifax this period.

  • New healthcare screening product expands verification business Equifax launched Healthcare Report Credential ID, an automated tool to verify healthcare licenses and certifications. With projected shortages of over 106,000 doctors and 267,000 nurses by 2027, hospitals need faster onboarding. This adds a new product to Equifax's fast-growing verification services, which already drive much of its profit growth.

    New product launch shows Equifax expanding its higher-margin verification business beyond traditional credit reports.

September 2026
▼4

FHFA Reforms Threaten Equifax's Mortgage Credit Reporting Business

  • FHFA Ends FICO Monopoly, VantageScore Allowed The FHFA directed Fannie Mae and Freddie Mac to let all lenders use VantageScore, ending FICO's monopoly. Equifax shares fell 6.8% as investors worried about pricing pressure on credit reports, even though Equifax co-owns VantageScore.

    This regulatory change directly threatens Equifax's mortgage credit reporting revenue and sparked the initial sell-off.

  • FHFA Unifies Mortgage Pricing Grid The FHFA announced a single pricing grid for Fannie and Freddie mortgages that includes VantageScore alongside FICO. Equifax fell 4.1% premarket as the move escalates pressure on credit bureau fees and could reduce revenue per mortgage.

    This is a new escalation that directly impacts Equifax's mortgage pricing and was not in earlier reports.

  • FHFA May Require Two Credit Bureaus (Bi-Merge) A Bloomberg report says the FHFA may require lenders to use two credit bureaus instead of three for mortgages. This would cut demand for Equifax's traditional three-bureau reports, pressuring volumes and pricing. The rule could be announced as soon as Oct. 12.

    This potential rule change is a new threat that could significantly reduce Equifax's mortgage report volumes.

  • Equifax Faces Mortgage Score Pressure as Fannie and Freddie Add VantageScore Fannie and Freddie are adding VantageScore to mortgage underwriting, and major lenders like Rocket Mortgage are preparing to adopt it. This could shift demand away from traditional credit reports and pressure Equifax's mortgage fee mix and volumes.

    This article summarizes the competitive pressure and potential revenue mix shift, reinforcing the negative outlook.

▼4

FHFA Reforms Threaten Equifax's Mortgage Credit Reporting Business

  • FHFA Ends FICO Monopoly, VantageScore Allowed The FHFA directed Fannie Mae and Freddie Mac to let all lenders use VantageScore, ending FICO's monopoly. Equifax shares fell 6.8% as investors worried about pricing pressure on credit reports, even though Equifax co-owns VantageScore.

    This regulatory change directly threatens Equifax's mortgage credit reporting revenue and sparked the initial sell-off.

  • FHFA Unifies Mortgage Pricing Grid The FHFA announced a single pricing grid for Fannie and Freddie mortgages that includes VantageScore alongside FICO. Equifax fell 4.1% premarket as the move escalates pressure on credit bureau fees and could reduce revenue per mortgage.

    This is a new escalation that directly impacts Equifax's mortgage pricing and was not in earlier reports.

  • FHFA May Require Two Credit Bureaus (Bi-Merge) A Bloomberg report says the FHFA may require lenders to use two credit bureaus instead of three for mortgages. This would cut demand for Equifax's traditional three-bureau reports, pressuring volumes and pricing. The rule could be announced as soon as Oct. 12.

    This potential rule change is a new threat that could significantly reduce Equifax's mortgage report volumes.

  • Equifax Faces Mortgage Score Pressure as Fannie and Freddie Add VantageScore Fannie and Freddie are adding VantageScore to mortgage underwriting, and major lenders like Rocket Mortgage are preparing to adopt it. This could shift demand away from traditional credit reports and pressure Equifax's mortgage fee mix and volumes.

    This article summarizes the competitive pressure and potential revenue mix shift, reinforcing the negative outlook.

July 2026
▲2▼1

Equifax Expands in Mexico and AI Savings, but Margin Pressures Weigh

  • Mexico Acquisition Expands Footprint Equifax agreed to buy Mexico's Círculo de Crédito for $750 million, adding a fast-growing credit bureau with $134 million in revenue and 46% EBITDA margin. This should boost future earnings and opens a new market, but regulatory approval is pending.

    This is a major new growth driver that directly affects EFX's future revenue and earnings.

  • Q2 Earnings Beat but Guidance Disappoints Equifax reported Q2 revenue up 10.6% and adjusted EPS of $2.25, beating estimates. However, full-year and Q3 guidance came in below analyst expectations, sending the stock down 7%. The weak outlook is tied to a shrinking mortgage market.

    This is the key new financial report that shows current performance and future expectations, directly impacting investor sentiment.

  • AI Savings Target Doubled to $150 Million Equifax doubled its AI-driven cost savings goal to $150 million for 2026-2028, using AI to improve efficiency. This should help offset margin pressures and boost profitability over time.

    This is a new strategic initiative that could improve future margins and profitability.

  • Margin Pressures and Weak Mortgage Market Despite revenue growth, adjusted EBITDA margins fell across all segments, and rising compensation and tech costs are squeezing profits. The mortgage market remains weak with high rates, hurting a key revenue source.

    This explains the negative stock reaction and highlights ongoing challenges that could limit upside.

▲2▼1

Equifax Expands in Mexico and AI Savings, but Margin Pressures Weigh

  • Mexico Acquisition Expands Footprint Equifax agreed to buy Mexico's Círculo de Crédito for $750 million, adding a fast-growing credit bureau with $134 million in revenue and 46% EBITDA margin. This should boost future earnings and opens a new market, but regulatory approval is pending.

    This is a major new growth driver that directly affects EFX's future revenue and earnings.

  • Q2 Earnings Beat but Guidance Disappoints Equifax reported Q2 revenue up 10.6% and adjusted EPS of $2.25, beating estimates. However, full-year and Q3 guidance came in below analyst expectations, sending the stock down 7%. The weak outlook is tied to a shrinking mortgage market.

    This is the key new financial report that shows current performance and future expectations, directly impacting investor sentiment.

  • AI Savings Target Doubled to $150 Million Equifax doubled its AI-driven cost savings goal to $150 million for 2026-2028, using AI to improve efficiency. This should help offset margin pressures and boost profitability over time.

    This is a new strategic initiative that could improve future margins and profitability.

  • Margin Pressures and Weak Mortgage Market Despite revenue growth, adjusted EBITDA margins fell across all segments, and rising compensation and tech costs are squeezing profits. The mortgage market remains weak with high rates, hurting a key revenue source.

    This explains the negative stock reaction and highlights ongoing challenges that could limit upside.